• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中长效牙周再生/重建术治疗骨内缺损的临床获益:随机对照临床试验的系统评价和网状 Meta 分析。

Medium- and long-term clinical benefits of periodontal regenerative/reconstructive procedures in intrabony defects: Systematic review and network meta-analysis of randomized controlled clinical studies.

机构信息

Division of Regenerative Dentistry and Periodontology, University Clinics of Dental Medicine (CUMD), University of Geneva, Geneva, Switzerland.

Department of Periodontology, Faculty of Odontology, University of Malmö, Sweden.

出版信息

J Clin Periodontol. 2021 Mar;48(3):410-430. doi: 10.1111/jcpe.13409. Epub 2021 Jan 21.

DOI:10.1111/jcpe.13409
PMID:33289191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7986220/
Abstract

BACKGROUND

Systematic reviews have established the short-term improvements of periodontal regenerative/reconstructive procedures compared to conventional surgical treatment in intrabony defects. However, a hierarchy of periodontal regenerative/reconstructive procedures regarding the medium- to long-term results of treatment does not exist.

AIM

To systematically assess the literature to answer the focused question "In periodontitis patients with intrabony defects, what are the medium- and long-term benefits of periodontal regenerative/reconstructive procedures compared with open flap debridement (OFD), in terms of clinical and/or radiographic outcome parameters and tooth retention?".

MATERIAL & METHODS: Randomized controlled clinical trials (RCTs), reporting on clinical and/or radiographic outcome parameters of periodontal regenerative/reconstructive procedures ≥3 years post-operatively, were systematically assessed. Clinical [residual probing pocket depth (PD) and clinical attachment level (CAL) gain, tooth loss] and radiographic [residual defect depth (RDD), bone gain (RBL)] outcome parameters were assessed. Descriptive statistics were calculated, and Bayesian random-effects network meta-analyses (NMA) were performed where possible.

RESULTS

Thirty RCTs, presenting data 3 to 20 years after treatment with grafting, GTR, EMD, as monotherapies, combinations thereof, and/or adjunctive use of blood-derived growth factor constructs or with OFD only, were included. NMA based on 21 RCTs showed that OFD was clearly the least efficacious treatment; regenerative/reconstructive treatments resulted in significantly shallower residual PD in 4 out 8 comparisons [range of mean differences (MD): -2.37 to -0.60 mm] and larger CAL gain in 6 out 8 comparisons (range of MD: 1.26 to 2.66 mm), and combination approaches appeared as the most efficacious. Tooth loss after regenerative/reconstructive treatment was less frequent (0.4%) compared to OFD (2.8%), but the evidence was sparse. There were only sparse radiographic data not allowing any relevant comparisons.

CONCLUSION

Periodontal regenerative/reconstructive therapy in intrabony defects results, in general, in shallower residual PD and larger CAL gain compared with OFD, translating in high rates of tooth survival, on a medium (3-5 years) to long-term basis (5-20 years). Combination approaches appear, in general, more efficacious compared to monotherapy in terms of shallower residual PD and larger CAL gain. A clear hierarchy could, however, not be established due to limited evidence.

摘要

背景

系统评价已经证实,与传统手术治疗相比,牙周再生/重建程序在骨内缺损方面具有短期改善效果。然而,针对牙周再生/重建程序在中-长期治疗效果方面,并不存在一种分层体系。

目的

系统评估文献,以回答以下具体问题:“在患有骨内缺损的牙周炎患者中,与翻瓣清创术(OFD)相比,牙周再生/重建程序在中-长期内,从临床和/或影像学结果参数以及保留牙齿的角度来看,具有哪些优势?”

材料和方法

系统性评估了随机对照临床试验(RCT),这些 RCT 报告了牙周再生/重建程序在术后至少 3 年的临床和/或影像学结果参数。评估了临床(剩余探诊深度(PD)和临床附着水平(CAL)的获得、牙齿缺失)和影像学(剩余缺损深度(RDD)、骨获得(RBL))的结果参数。计算了描述性统计数据,并在可能的情况下进行了贝叶斯随机效应网络荟萃分析(NMA)。

结果

纳入了 30 项 RCT,这些 RCT 在单独使用移植物、GTR、EMD 或联合使用血液衍生生长因子构建体或仅进行 OFD 治疗后 3 至 20 年报告了数据。基于 21 项 RCT 的 NMA 结果显示,OFD 是最无效的治疗方法;再生/重建治疗在 8 项比较中有 4 项(平均差值(MD)范围:-2.37 至-0.60mm)和 6 项比较中(MD 范围:1.26 至 2.66mm)具有明显更浅的剩余 PD,且联合治疗方法的效果似乎最佳。与 OFD(2.8%)相比,再生/重建治疗后的牙齿缺失频率较低(0.4%),但证据稀疏。仅有少量的放射影像学数据,不允许进行任何相关比较。

结论

与 OFD 相比,骨内缺损的牙周再生/重建治疗通常会导致更浅的剩余 PD 和更大的 CAL 获得,从而在中短期(3-5 年)至长期(5-20 年)内保持较高的牙齿存活率。与单药治疗相比,联合治疗方法在剩余 PD 变浅和 CAL 获得更大方面通常更有效。然而,由于证据有限,因此无法确定明确的分层体系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7986220/903b1133de99/JCPE-48-410-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7986220/2b25d7090e7e/JCPE-48-410-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7986220/0806eb0a3f81/JCPE-48-410-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7986220/5fea08226e57/JCPE-48-410-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7986220/903b1133de99/JCPE-48-410-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7986220/2b25d7090e7e/JCPE-48-410-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7986220/0806eb0a3f81/JCPE-48-410-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7986220/5fea08226e57/JCPE-48-410-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/7986220/903b1133de99/JCPE-48-410-g001.jpg

相似文献

1
Medium- and long-term clinical benefits of periodontal regenerative/reconstructive procedures in intrabony defects: Systematic review and network meta-analysis of randomized controlled clinical studies.中长效牙周再生/重建术治疗骨内缺损的临床获益:随机对照临床试验的系统评价和网状 Meta 分析。
J Clin Periodontol. 2021 Mar;48(3):410-430. doi: 10.1111/jcpe.13409. Epub 2021 Jan 21.
2
Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.釉基质衍生物(Emdogain)用于骨内缺损牙周组织再生的Cochrane系统评价。
Eur J Oral Implantol. 2009 Winter;2(4):247-66.
3
Guided tissue regeneration for periodontal infra-bony defects.牙周骨下袋缺损的引导组织再生术。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD001724. doi: 10.1002/14651858.CD001724.pub2.
4
Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects.用于骨内缺损牙周组织再生的釉基质衍生物(Emdogain®)
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003875. doi: 10.1002/14651858.CD003875.pub3.
5
Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.釉基质衍生物(Emdogain)用于骨内缺损的牙周组织再生。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD003875. doi: 10.1002/14651858.CD003875.pub2.
6
Guided tissue regeneration for the treatment of periodontal intrabony and furcation defects. A systematic review.引导组织再生术治疗牙周骨内和根分叉病变的系统评价
Ann Periodontol. 2003 Dec;8(1):266-302. doi: 10.1902/annals.2003.8.1.266.
7
Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.用于骨内缺损牙周组织再生的釉基质衍生物(Emdogain)。
Cochrane Database Syst Rev. 2003(2):CD003875. doi: 10.1002/14651858.CD003875.
8
Growth and amelogenin-like factors in periodontal wound healing. A systematic review.牙周伤口愈合中的生长因子和类釉原蛋白因子。一项系统评价。
Ann Periodontol. 2003 Dec;8(1):193-204. doi: 10.1902/annals.2003.8.1.193.
9
Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis.富血小板纤维蛋白用于治疗牙周骨内缺损:一项系统评价和荟萃分析。
Clin Oral Investig. 2021 May;25(5):2461-2478. doi: 10.1007/s00784-021-03825-8. Epub 2021 Feb 20.
10
Guided tissue regeneration for periodontal infra-bony defects.牙周骨下缺损的引导组织再生术
Cochrane Database Syst Rev. 2001(2):CD001724. doi: 10.1002/14651858.CD001724.

引用本文的文献

1
Advances in orthodontic treatment for periodontal disease: a bibliometric analysis, emerging insights and clinical implications.牙周病正畸治疗的进展:文献计量分析、新见解及临床意义
Front Dent Med. 2025 Jul 24;6:1600672. doi: 10.3389/fdmed.2025.1600672. eCollection 2025.
2
Regenerative Management of a Late Endoperiodontal Complication After Phased Perio-Orthodontic Therapy: A Case Report.分阶段牙周正畸治疗后晚期牙周膜内并发症的再生治疗:一例报告
Cureus. 2025 Aug 6;17(8):e89462. doi: 10.7759/cureus.89462. eCollection 2025 Aug.
3
Advancement in smart bone implants: the latest multifunctional strategies and synergistic mechanisms for tissue repair and regeneration.

本文引用的文献

1
Treatment of intrabony defects with modified perforated membranes in aggressive periodontitis: a 4-year follow-up of a randomized controlled trial.用改良的穿孔膜治疗侵袭性牙周炎的骨内缺损:一项随机对照试验的 4 年随访。
Clin Oral Investig. 2020 Mar;24(3):1183-1196. doi: 10.1007/s00784-019-02982-1. Epub 2019 Jul 19.
2
Infrabony defects 20 years after open flap debridement and guided tissue regeneration.翻开式清创及引导组织再生术后 20 年的牙周骨缺损。
J Clin Periodontol. 2019 May;46(5):552-563. doi: 10.1111/jcpe.13110.
3
Periodontal regeneration compared with access flap surgery in human intra-bony defects 20-year follow-up of a randomized clinical trial: tooth retention, periodontitis recurrence and costs.
智能骨植入物的进展:组织修复与再生的最新多功能策略及协同机制
Bioact Mater. 2025 May 19;51:333-382. doi: 10.1016/j.bioactmat.2025.05.004. eCollection 2025 Sep.
4
Guided Tissue Regeneration of Periodontal Infrabony Defects with Frozen Radiation-Sterilized Allogenic Bone Graft Versus Deproteinized Bovine Bone Mineral: 5-Year Outcomes of RCT.冷冻辐射灭菌同种异体骨移植与脱蛋白牛骨矿物质引导牙周骨下袋缺损组织再生:随机对照试验的5年结果
J Funct Biomater. 2025 Mar 10;16(3):95. doi: 10.3390/jfb16030095.
5
Bony Defect Regeneration in Periodontitis: A Systematic Review of the Literature Regarding the Use of Enamel Matrix Derivative Proteins.牙周炎中的骨缺损再生:关于牙釉质基质衍生蛋白应用的文献系统评价
Dent J (Basel). 2025 Feb 20;13(3):92. doi: 10.3390/dj13030092.
6
Development and validation of a polyfit approach for assessing alveolar bone loss using panoramic radiography.一种使用全景X线摄影评估牙槽骨吸收的多项式拟合方法的开发与验证
BMC Oral Health. 2025 Mar 21;25(1):417. doi: 10.1186/s12903-025-05714-y.
7
Comparision of crosslinked hyaluronic acid vs. enamel matrix derivative for periodontal regeneration: an 18-month follow-up randomized clinical trial.交联透明质酸与釉基质衍生物用于牙周再生的比较:一项18个月随访的随机临床试验。
Clin Oral Investig. 2025 Mar 19;29(4):197. doi: 10.1007/s00784-025-06278-5.
8
Low-Speed Platelet-Rich Fibrin Membrane in Conjunction With Demineralized Freeze-Dried Bone Allograft (DFDBA) Compared to Collagen Membrane With DFDBA in Noncontained Intraosseous Defects of Stage III Periodontitis: A Randomized Controlled Clinical Trial.低速富血小板纤维蛋白膜联合脱矿冻干骨同种异体移植物(DFDBA)与胶原膜联合DFDBA治疗Ⅲ期牙周炎非包容性骨内缺损的随机对照临床试验。
Int J Dent. 2025 Feb 23;2025:6393105. doi: 10.1155/ijod/6393105. eCollection 2025.
9
Beyond Bone Grafts: Exploring the Efficacy of Alternative Regenerative Therapies.超越骨移植:探索替代再生疗法的疗效
Cureus. 2024 Nov 15;16(11):e73745. doi: 10.7759/cureus.73745. eCollection 2024 Nov.
10
Combination of Enamel Matrix Derivatives with Bone Graft vs Bone Graft Alone in the Treatment of Periodontal Intrabony and Furcation Defects: A Systematic Review and Meta-Analysis.牙釉质基质衍生物与骨移植联合应用与单纯骨移植治疗牙周骨内及根分叉病变的系统评价和Meta分析
Oral Health Prev Dent. 2024 Dec 5;22:655-664. doi: 10.3290/j.ohpd.b5871494.
牙周再生与翻瓣术治疗人牙槽骨内缺损的 20 年随机临床试验比较:保留牙齿、牙周炎复发和成本。
J Clin Periodontol. 2017 Jan;44(1):58-66. doi: 10.1111/jcpe.12638. Epub 2016 Nov 22.
4
The effect of platelet-rich plasma on clinical outcomes of the surgical treatment of periodontal intrabony defects: A systematic review and meta-analysis.富血小板血浆对牙周骨内缺损手术治疗临床疗效的影响:一项系统评价与Meta分析。
BMC Oral Health. 2016 Aug 17;16(1):71. doi: 10.1186/s12903-016-0261-5.
5
Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft.单独使用釉基质衍生物或联合合成骨移植治疗晚期骨内缺损的再生性牙周手术三年结果
Clin Oral Investig. 2016 Mar;20(2):357-64. doi: 10.1007/s00784-015-1522-4. Epub 2015 Jul 15.
6
Biomaterials for promoting periodontal regeneration in human intrabony defects: a systematic review.促进人牙槽骨内缺损牙周再生的生物材料:系统评价。
Periodontol 2000. 2015 Jun;68(1):182-216. doi: 10.1111/prd.12086.
7
Outcomes of regenerative treatment with rhPDGF-BB and rhFGF-2 for periodontal intra-bony defects: a systematic review and meta-analysis.rhPDGF-BB 和 rhFGF-2 再生治疗牙周骨内缺损的疗效:系统评价和荟萃分析。
J Clin Periodontol. 2015 Mar;42(3):272-80. doi: 10.1111/jcpe.12354. Epub 2015 Feb 20.
8
Periodontal regeneration - intrabony defects: a systematic review from the AAP Regeneration Workshop.牙周组织再生——骨内缺损:美国牙周病学会再生研讨会的系统评价
J Periodontol. 2015 Feb;86(2 Suppl):S77-104. doi: 10.1902/jop.2015.130685. Epub 2014 Sep 12.
9
Efficacy of enamel matrix derivative with freeze-dried bone allograft or demineralized freeze-dried bone allograft in intrabony defects: a randomized trial.釉基质衍生物与冻干同种异体骨或脱矿冻干同种异体骨治疗骨内缺损的疗效:一项随机试验。
J Periodontol. 2014 Oct;85(10):1351-60. doi: 10.1902/jop.2014.130520. Epub 2014 Mar 24.
10
Which biomaterials may promote periodontal regeneration in intrabony periodontal defects? A systematic review of preclinical studies.哪些生物材料可促进骨内牙周缺损的牙周组织再生?一项临床前研究的系统评价。
Quintessence Int. 2014 May;45(5):385-95. doi: 10.3290/j.qi.a31538.